We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
-13.15%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$3.53B
AUM Growth
-$515M
Cap. Flow
+$82.4M
Cap. Flow %
2.34%
Top 10 Hldgs %
17.59%
Holding
1,694
New
254
Increased
545
Reduced
799
Closed
63

Top Buys

Rank Stock Value
1
IWV icon
iShares Russell 3000 ETF
IWV
+$18.7M
2
LIN icon
Linde
LIN
+$12M
3
CI icon
Cigna
CI
+$3.39M
4
CVS icon
CVS Health
CVS
+$2.48M
5
AMD icon
Advanced Micro Devices
AMD
+$1.86M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$8.78M
2
PX
Praxair Inc
PX
+$6.86M
3
ESRX
Express Scripts Holding Company
ESRX
+$6.82M
4
AAPL icon
Apple
AAPL
+$6.25M
5
MSFT icon
Microsoft
MSFT
+$3.17M

Sector Composition

Rank Sector Weight
1 Technology 18.1%
2 Healthcare 14.6%
3 Financials 14.41%
4 Consumer Discretionary 10.56%
5 Industrials 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPCH icon
1551
Option Care Health
OPCH
$3.4B
$62K ﹤0.01%
4,334
+347
+9% +$4.58K
ATRS
1552
DELISTED
Antares Pharma, Inc.
ATRS
$59K ﹤0.01%
+21,766
New +$71.7K
FRO icon
1553
Frontline
FRO
$8.75B
$58K ﹤0.01%
10,501
PDLI
1554
DELISTED
PDL BioPharma, Inc.
PDLI
$58K ﹤0.01%
19,986
HLIT icon
1555
Harmonic Inc
HLIT
$1.21B
$57K ﹤0.01%
11,981
+60
+0.5% +$327
NOG icon
1556
Northern Oil and Gas
NOG
$2.3B
$57K ﹤0.01%
2,504
+261
+12% +$7.67K
RIGL icon
1557
Rigel Pharmaceuticals
RIGL
$680M
$57K ﹤0.01%
2,469
+1,388
+128% +$39.2K
ENPH icon
1558
Enphase Energy
ENPH
$4.84B
$56K ﹤0.01%
11,790
ASXC
1559
DELISTED
Asensus Surgical, Inc.
ASXC
$54K ﹤0.01%
+1,830
New +$83.2K
EXPR
1560
DELISTED
Express, Inc.
EXPR
$54K ﹤0.01%
528
-3
-0.6% -$463
ANH
1561
DELISTED
Anworth Mortgage Asset Corporation
ANH
$53K ﹤0.01%
13,049
PGNX
1562
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$53K ﹤0.01%
+12,583
New +$64.1K
NIHD
1563
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$53K ﹤0.01%
12,047
WTI icon
1564
W&T Offshore
WTI
$545M
$51K ﹤0.01%
12,463
DF
1565
DELISTED
Dean Foods Company
DF
$51K ﹤0.01%
13,283
+14
+0.1% +$85
INO icon
1566
Inovio Pharmaceuticals
INO
$79.8M
$50K ﹤0.01%
+1,032
New +$62.7K
MOBL
1567
DELISTED
MobileIron, Inc.
MOBL
$50K ﹤0.01%
+10,817
New +$50.7K
DHT icon
1568
DHT Holdings
DHT
$2.97B
$49K ﹤0.01%
12,380
JCP
1569
DELISTED
J.C. Penney Company, Inc.
JCP
$48K ﹤0.01%
45,770
+75
+0.2% +$105
TYME
1570
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$47K ﹤0.01%
+12,612
New +$35.4K
CBL
1571
DELISTED
CBL& Associates Properties, Inc.
CBL
$47K ﹤0.01%
24,562
+32
+0.1% +$94
AKRX
1572
DELISTED
Akorn Inc
AKRX
$47K ﹤0.01%
13,769
+1,138
+9% +$6.77K
AHT
1573
Ashford Hospitality Trust
AHT
$21M
$46K ﹤0.01%
12
FET icon
1574
Forum Energy Technologies
FET
$654M
$45K ﹤0.01%
546
XXII
1575
22nd Century Group
XXII
$1.47M
0

Similar funds

Amalgamated Bank's Q4 2018 Portfolio in Review

As of Q4 2018, Amalgamated Bank held 1,694 positions worth $3.53B, down 13% from $4.04B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Amalgamated Bank's Q4 2018 filing shows 254 new, 545 increased, 799 reduced and 63 closed positions. Its largest new stake was Linde: 75,865 shares worth $11.8M. The largest sale was Aetna Inc, an estimated $8.78M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Amalgamated Bank's largest Q4 2018 buy was Linde: 75,865 shares worth $11.8M.
  • Amalgamated Bank added most to iShares Russell 3000 ETF in Q4 2018, an estimated $18.7M increase.
  • Amalgamated Bank's biggest Q4 2018 reduction was Apple, cutting an estimated $6.25M.
  • Amalgamated Bank fully exited Aetna Inc in Q4 2018, selling an estimated $8.78M.
  • Amalgamated Bank's ten largest holdings make up 18% of its $3.53B portfolio in Q4 2018.
  • Amalgamated Bank opened 254 new positions and closed 63 in Q4 2018.
  • Amalgamated Bank's portfolio value fell 13% quarter-over-quarter to $3.53B.

Based on Amalgamated Bank's 13F filing for Q4 2018, filed 15 Feb 2019.